07:00 , May 7, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Importin 7 (IPO7); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1)

Cancer INDICATION: Cancer In vitro and mouse studies suggest a peptide inhibitor of IPO7 binding to MAPK1 or MAPK3 could help treat cancer. In multiple human cancer cell lines, a cell-penetrating peptide derived from MAPK1...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension Postmeiotic segregation increased 1 (PMS1); solute carrier family 24 sodium/potassium/calcium exchanger member 4 (SLC24A4); tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, z-polypeptide (YWHAZ); importin 7...
07:00 , Jul 13, 2009 |  BioCentury  |  Emerging Company Profile

NanoVector: Planted in the nucleus

NanoVector Inc. believes its plant virus-based nanoparticle technology will allow it to deliver drugs precisely inside targeted cells, reducing side effects and improving the efficacy of chemotherapeutics and other drugs. The technology exploits the chemical...